Can COX-2 Inhibitor Decrease Stricture Recurrence After Direct Vision Internal Urethrotomy?

NCT06697106•New Valley University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

COX-2 InhibitorMeloxicamStricture Recurrence+1 more

Interventions

Nonsteroidal anti-inflammatory drugs

Placebo

Locations

Egypt

Locations (1)

New Valley University

New Valley, New Valley Governorate, Egypt

Key Dates

Start Date

November 20, 2024

Primary Completion Date

April 1, 2025

Completion Date

April 1, 2025

Last Updated

November 21, 2024

Contacts

Waheed F Abdelrasol, MD

CONTACT

00201207722518 waheed_fawzy@med.nvu.edu.eg

Sponsors

Lead Sponsor

New Valley University

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 21, 2024Data synced to Clareo: April 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions